TITLE

Sequential vs. simultaneous antiretroviral HIV therapy

AUTHOR(S)
Huffman, Grace Brooke
PUB. DATE
November 1998
SOURCE
American Family Physician;11/15/1998, Vol. 58 Issue 8, p1845
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on how antiretroviral therapy that consists of a combination of two nucleoside analog reverse transcriptase inhibitors can suppress viral load in patients with human immunodefiency virus (HIV) infection. Methods used in the study; Results and discussion; Conclusion.
ACCESSION #
1327572

 

Related Articles

  • Efficacy and Safety of Emtricitabine vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: A Randomized Trial. Saag, Michael S.; Cahn, Pedro; Raffi, François; Wolff, Marcelo; Pearce, Daniel; Molina, Jean-Michel; Powderly, William; Shaw, Audrey L.; Mondou, Elsa; Hinkle, John; Borroto-Esoda, Katyna; Quinn, Joseph B.; Barry, David W.; Rousseau, Franck // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p180 

    Context Emtricitabine is a new, once-daily nucleoside reverse transcriptase inhibitor (NRTI) with potent activity against human immunodeficiency virus (HIV). Objective To assess the efficacy and safety of emtricitabine as compared with stavudine when used with a background regimen of didanosine...

  • Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients: A 3-Year Randomized Trial. Gallant, Joel E.; Staszewski, Schlomo; Pozniak, Anton L.; DeJesus, Edwin; Suleiman, Jamal M. A. H.; Miller, Michael D.; Coakley, Dion F.; Lu, Biao; Toole, John J.; Cheng, Andrew K. // JAMA: Journal of the American Medical Association;7/14/2004, Vol. 292 Issue 2, p191 

    Context Tenofovir disoproxil fumarate (DF) is a once-daily nucleotide analogue reverse transcriptase inhibitor. Objective To evaluate the efficacy and safety of tenofovir DF compared with stavudine in antiretroviral-naive patients. Design, Setting, and Participants A prospective, randomized,...

  • Medication therapy among intravenous drug users (IDUs) with HIV infection. Smith, Prince C.; Page, J. Bryan // AIDS Patient Care & STDs;Apr96, Vol. 10 Issue 2, p101 

    Evaluates the use of antiretroviral agents among HIV-positive intravenous drug users (IDU) in Miami, Florida. Medical and social service for HIV-positive IDU; Side effects of antiretroviral agents experienced by IDU; Adherence to medical regimens.

  • Closer, but still no cure. Brink, Susan // U.S. News & World Report;02/16/98, Vol. 124 Issue 6, p73 

    Focuses on the possible impact of an apparent HIV-remission caused by drug therapies in a patient in Germany. Details of the drug combination therapy; Dramatic decrease in the patient's viral load; Evidence of the virus still present in his system; Efforts to develop simple drug regimens.

  • Once-daily darunavir approved for treatmentexperienced adults with HIV.  // British Journal of Hospital Medicine (17508460);Apr2011, Vol. 72 Issue 4, p189 

    The article reports that the European Union (EU) has approved once-daily Prezista (darunavir) tablets in combination with ritonavir for treatment-experienced adults with human immunodeficiency virus (HIV).

  • Combo therapy promising.  // Drug Topics;8/22/94, Vol. 138 Issue 16, p8 

    Reports that combination therapy with zidovudine, zalcitabine and saquinavir is more effective that a two-drug regimen in reducing blood levels of the human immunodeficiency syndrome virus.

  • New Class Of Drug Against HIV Gets Accelerated Approval.  // RN;Jun2003, Vol. 66 Issue 6, p94 

    Reports on the U.S. Food and Drug Administration's approval of a class of drug for use in combination with other agents to treat advanced HIV-1 infection. Fusion inhibition mechanism of the drug; Possible side effects.

  • Darunavir in the Treatment of HIV-1 Infection. Holodniy, Mark // Drugs;2007, Vol. 67 Issue 18, p2803 

    This article comments on the study in this issue which looked at the use of darunavir in the treatment of HIV-1 infections. It is recommended that HIV-positive people undergo combination therapy from two drug classes and while the combination therapy has resulted in suppression of viral...

  • Malaria and HIV: demystifying the often misunderstood relationship. Brieger, William R. // Africa Health;Jul2011, Vol. 33 Issue 5, p14 

    The article explores the relationship between malaria and HIV/AIDS. It was found that there is a biological interaction in people who are co-infected with both diseases. It emphasizes that co-infections have the tendency to increase HIV viral load in population with acute malaria. It stresses...

  • Quantifying the activity of anti-HIV treatment in silico. Ribeiro, Ruy M // Nature Medicine;Mar2012, Vol. 18 Issue 3, p355 

    An introduction to the journal is presented in which the author discusses an article on the combination of three antiretroviral drugs for anti-HIV treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics